Onkos Surgical® expands access to NanoCept® Antibacterial Technology for patients requiring total femoral replacement

Onkos Surgical announced the market release of its ELEOS Total Femoral Adapter featuring NanoCept antibacterial technology. The launch expands NanoCept availability for patients undergoing complex, high-risk total femoral procedures, potentially strengthening Onkos Surgical's orthopedic oncology product offering. No financial contribution, regulatory milestone, or sales outlook was disclosed.